J&J exits the RSV vaccine development race with competitors Pfizer and GSK
March 30, 2023: On Wednesday, Johnson & Johnson said it’s ducking out of the RSV vaccine race, weeks following competitors Pfizer …
- April 2, 2023 1:45 am
- California
January 25, 2021: Johnson & Johnson board member Dr. Mark McClellan said, “if the clinical trial works out,” the company could significantly increase the nation’s COVID-19 vaccine supply available within the coming weeks.
Johnson & Johnson has enough data regarding its vaccine to begin analysis in the coming week or two, Dr. Fauci said on Thursday.
The important thing for the company’s vaccine is the large-scale clinical trial underway now, said McClellan.
“The independent scientists who are viewing that study should be taking a close look very shortly based on the results, and we’ll see how fast the vaccine could go forward,” McClellan said.
According to the Centers for Disease Control and Prevention, the U.S. averaged 883,000 jabs of the COVID-19 vaccine per day. However, under 50% of the 37,960,000 doses distributed have made their way into people’s arms. Minimum 12 states have reported vaccine shortages.
McClellan noted that the supply should increase, but probably not enough to keep up with many Americans wanting to get vaccinated.
“It’s going to be challenging, but I think the supply will be there over the next couple of months to vaccinate even more than 100 million Americans,” said McClellan.
On Thursday, President Joe Biden promised a “full-scale, wartime effort” to fight against the deadly pandemic and start vaccine production using the Defense Production Act.
“We’ve already identified suppliers and are working with them to move the plan forward,” Biden said.
We provide the insights on leaders who are responsible for taking their organization to new heights, all the while bringing together a group of talented individuals.
March 30, 2023: On Wednesday, Johnson & Johnson said it’s ducking out of the RSV vaccine race, weeks following competitors Pfizer …
March 30, 2023: On Wednesday, Ovo Energy plans to seize Shell Plc’s UK gas and electricity business. Sky News reported that …
March 30, 2023: On Wednesday, Bitcoin ascended as investors shrugged off initial fears about what is surrounding U.S. regulators’ crackdowns …
Trōv is a global leader in embedded insurance, powering the future of digital insurance distribution and emerging mobility. Its robust insurtech platform empowers financial institutions and insurance incumbents to easily embed insurance products within other digital experiences to increase recurring revenue.
While only one in ten homes throughout the United States has flood insurance coverage, floods are the country’s most common and deadli-est natural disaster. Since 2000, they have cost American taxpayers $850 billion, two-thirds of the total cost of all natural disasters, yet only 1 out of 10 homes are insured for flood, and that number could soon be reduced.
Insurance needs to be more precise as there are solutions that protect the assets owned by the Property Managers (apartment units) and solutions that protect the Residents and their personal belongings. Which programs to offer and buy depends on each unique client’s needs.